Combination of panthenol, madecassoside and niacinamide in multi-lamellar emulsion as postprocedural laser treatment
Abstract
Laser resurfacing procedure in dermatology involves creating superficial wound. Erythema, edema, and scaling are common and temporary side effects. We report three patients which were given topical combination cream containing panthenol, madecassoside, and niacinamide in multi-lamellar emulsion (MLE) following laser skin resurfacing procedure. The combination cream was given to two patients receiving Q-switched Nd:YAG (RevLite®, Cynosure®, Massachusetts, USA) laser treatment and one patient receiving fractional CO2 (Bioxel®, AMI Inc®, Seoul, South Korea) laser treatment. Erythema and edema diminish gradually in 7 days after treatment. This may be due to the anti-inflammatory effects of panthenol, madecassoside, and niacinamide. MLE also may contribute to repairing the damaged skin barrier after procedure, thus supporting the superficial wound healing. Topical combination consisting of panthenol, madecassoside, and niacinamide in MLE may ameliorate various side effects following laser procedures in dermatology. However, further research with better methodology and greater sample size is needed Key words Panthenol; Madecassoside; Niacinamide; Postprocedure; Laser treatment.References
Li D, Lin SB, Cheng B. Complications and posttreatment care following invasive laser skin resurfacing: a review. J Cosmet Laser Ther. 2018;20(3):168-78.
Eimpunth S, Wanitphadeedecha R, Manuskiatti W. A focused review on acne-induced and aesthetic procedure-related postinflammatory hyperpigmentation in Asians. J Eur Acad Dermatol Venereol. 2013;27 Suppl 1:7-18.
Al-niami F. Laser and energy-based devices’ complications in dermatology. J Cosmet Laser Ther. 2016;18(1):25-30.
Simbolon Sitohang IB, Sirait SAP, Safira FD. Fractional carbon dioxide laser for treating hypertrophic scars: a systematic review of randomised trials. Australas J Dermatol. 2022;63(1):27-35.
McIlwee B, Aster TS. Laser skin resurfacing: cosmetic and medical applications. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, editor. Fitzpatrick's dermatology. 9 ed. New York: McGraw-Hill; 2019. p. 3834-45.
Wong I, Richer V. Prophylaxis of post-inflammatory hyperpigmentation from energy-based device treatments: a review. J Cutan Med Surg. 2021;25(1):77-86.
Proksch E, deBony R, Trapp S, Boudon S. Topical use of dexpanthenol: a 70th anniversary article. J Dermatolog Treat. 2017;28(1):766-73.
Gorski J, Proksch E, Baron JM, Schmid D, Xhang L. Dexpanthenol in wound healing after medical and cosmetic interventions (postprocedure wound healing). Pharmaceuticals. 2020;13(1):138.
Tan S, Bhattamisra SK, Chellappan DK, Candasamy M. Actions and therapeutic potential of madecassoside and other major constituents of centella asiatica: a review. Appl Sci. 2021;11(1):8475.
Luengarun S, Srituravanit A, Tempark T. Efficacy and safety of moisturizer containing 5% panthenol, madecassoside, and copper-zinc-manganese versus 0.02% triamcinolone acetonide cream in decreasing adverse reaction and downtime after ablative fractional carbon dioxide laser resurfacing: A split-face, double-blinded, randomized, controlled trial. J Cosmet Dermatol. 2019;18(6):1751-7.
Bains P, Kaur M, Kaur J, Sharma S. Nicotinamide: mechanism of action and indications in dermatology. Indian J Dermatol Venereol Leprol. 2018;84(2):234-7.
Sul GD, Park HJ, Bae JH, Hong KD, Park BD, Chun J, et al. Preventive effects of multi-lamellar emulsion on low potency topical steroid induced local adverse effect. Ann Dermatol. 2013;25(1):5-11.
